Standard embryo storage fees are assessed when both client depositors (or gamete donors) have completed and are non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Embryos will be accepted without Anti-HIV 1 & 2 (AIDS), however, Potentially Infectious storage fees will be assessed.
We will accept embryos from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed. Read more about Potentially Infectious storage.
Embryos created with donor eggs or donor sperm will require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing prior to the release of embryos from storage with ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.
Standard storage fees are assessed for individuals (or gamete donors) who have completed and are non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Sperm or Testicular Tissue specimens will be accepted without Anti-HIV 1 & 2 (AIDS), however, Potentially Infectious storage fees will be assessed.
We will accept semen or tissue specimens from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed. Read more about Potentially Infectious storage.
Donor specimens require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing prior to the release of embryos from storage with ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.
Standard storage fees are assessed when the client depositor has completed and is non-reactive for at least Anti-HIV 1 & 2 (AIDS) testing. Oocytes or Ovarian Tissue will be accepted without Anti-HIV 1 & 2 (AIDS), however, Potentially Infectious storage fees will be assessed.
We will accept oocytes or tissue from patients who have tested reactive for one or more of the following: Anti-HIV 1 & 2, Hepatitis C – HCV, HTLV I & II, and Hepatitis B – HBsAg. Potentially Infectious storage fees will be assessed. Read more about Potentially Infectious storage.
Donor oocytes require additional testing and screening per FDA guidance.
Standards and/or Regulations require that patients complete the following serology/virology testing before the release of specimens from ReproTech for transfer back to a patient’s clinic for use: Hepatitis B – HBsAg, and Hepatitis C – Anti-HCV, in addition to Anti-HIV 1 & 2.